Skip to main content

All information is provided without guarantee.

see.ip is a service from the Austrian Patent Office.

info@patentamt.at

Impressum Datenschutz

Details for 2017710160

Up to date per 02.04.2026

Actions

Details for 2017710160

Title / Product Name

LIRAGLUTID BEI KARDIOVASKULÄREN STÖRUNGEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017710160

EP Publication Number

3423082

E-Number

1416273

Language

EN

PCT Number

EP17054990

Publication Date

09.01.2019 A

04.08.2021 B1

Registration Date

04.08.2021

AT Publication Date

15.08.2021

Application Date

03.03.2017

Registration Number

-

Priorities

04.03.2016

EP

16158739

10.06.2016

EP

16173917

13.06.2016

EP

16001329

09.01.2017

US

201715401651

IPC

A61K 38/26 20060101AFI20210302BHEP

Maximum Duration of Protection

03.03.2037

Owner

Novo Nordisk A/SNovo Allé 2880 BagsværdDK

Representative

Representative

Dipl.-Ing. Dr. Gerda RedlDonau-City-Straße 111220 WIENAT

Inventor

RASMUSSEN, SørenNovo Allé 2880 BagsværdDK

KVIST, KajsaNovo Allé 2880 BagsværdDK

Information about Fees